Skip to main content
Frontiers in Health Services logoLink to Frontiers in Health Services
. 2023 Aug 22;3:1209720. doi: 10.3389/frhs.2023.1209720

Rural barriers and facilitators of lung cancer screening program implementation in the veterans health administration: a qualitative study

Jennifer A Lewis 1,2,3,4,5,*, Kemberlee Bonnet 6,7, David G Schlundt 6,7, Susan Byerly 1,8, Christopher J Lindsell 9, Claudia I Henschke 10,11, David F Yankelevitz 10, Sally J York 2,3,5, Fred Hendler 12, Robert S Dittus 1,8, Timothy J Vogus 4,13, Sunil Kripalani 4,8, Drew Moghanaki 14,15, Carolyn M Audet 4,16, Christianne L Roumie 1,4,8,16, Lucy B Spalluto 1,4,5,17
PMCID: PMC10477991  PMID: 37674596

Abstract

Introduction

To assess healthcare professionals' perceptions of rural barriers and facilitators of lung cancer screening program implementation in a Veterans Health Administration (VHA) setting through a series of one-on-one interviews with healthcare team members.

Methods

Based on measures developed using Reach Effectiveness Adoption Implementation Maintenance (RE-AIM), we conducted a cross-sectional qualitative study consisting of one-on-one semi-structured telephone interviews with VHA healthcare team members at 10 Veterans Affairs medical centers (VAMCs) between December 2020 and September 2021. An iterative inductive and deductive approach was used for qualitative analysis of interview data, resulting in the development of a conceptual model to depict rural barriers and facilitators of lung cancer screening program implementation.

Results

A total of 30 interviews were completed among staff, providers, and lung cancer screening program directors and a conceptual model of rural barriers and facilitators of lung cancer screening program implementation was developed. Major themes were categorized within institutional and patient environments. Within the institutional environment, participants identified systems-level (patient communication, resource availability, workload), provider-level (attitudes and beliefs, knowledge, skills and capabilities), and external (regional and national networks, incentives) barriers to and facilitators of lung cancer screening program implementation. Within the patient environment, participants revealed patient-level (modifiable vulnerabilities) barriers and facilitators as well as ecological modifiers (community) that influence screening behavior.

Discussion

Understanding rural barriers to and facilitators of lung cancer screening program implementation as perceived by healthcare team members points to opportunities and approaches for improving lung cancer screening reach, implementation and effectiveness in VHA rural settings.

Keywords: lung cancer screening, barriers, facilitators, implementation science, low-dose CT, RE-AIM, rural

Introduction

Lung cancer screening with low-dose computed tomography (LDCT) in high-risk individuals is an evidence-based practice that improves lung cancer mortality (1, 2). It is recommended by the U.S. Preventive Services Task Force for individuals between the ages of 50 and 80 who have a tobacco history of at least 20 pack-years and currently or formerly smoked and quit within the past 15 years (3). It is also covered by Medicare in a similar patient population and is recommended by many professional organizations (4). Yet, while lung cancer screening is widely recommended, uptake in clinical practice is exceedingly low (5, 6), including in Veterans Health Administration (VHA) (7). Furthermore, approximately one quarter of Veterans reside in rural communities (8), and rural Veterans are less likely to undergo initial and subsequent lung cancer screening (9). The gap in effectively implementing this evidence-based practice may lead to missed opportunities to identify lung cancer early and improve patient health outcomes.

Translation of evidence-based practices to regular clinical practice is often delayed by many years (10, 11). Rigorous implementation science approaches can aid in expediting the translation of evidence-based practices such as lung cancer screening into regular clinical care to improve patient outcomes (12, 13). Understanding healthcare team members' perception of rural barriers and facilitators to implementation of lung cancer screening programs in VHA is an important initial step in developing an implementation science-driven approach to support high quality lung cancer screening that reaches all Veterans.

The objective of this study was to assess VHA radiology and primary care healthcare team members' perceptions of rural barriers and facilitators of lung cancer screening implementation through a series of one-on-one interviews. This study is embedded within a larger parent study, the Veterans Affairs Partnership to increase Access to Lung Screening (VA-PALS) Program Evaluation, that uses the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework to develop measures for evaluating lung cancer screening program implementation across 10 Veterans Affairs medical centers (VAMCs) (14).

Materials and methods

Study design and data sources

We conducted a cross-sectional qualitative study consisting of one-on-one semi-structured phone interviews with healthcare team members. Interviews lasted up to 1-hour. The findings of this study are reported following the guidelines of the Consolidated Criteria for Reporting Qualitative Studies, an evidence-based qualitative methodology (15). Agreement was obtained via telephone and documented.

This study was reviewed and approved by the Veterans Affairs (VA) Central Institutional Review Board (C-IRB E19-05), VA Tennessee Valley Healthcare System Research & Development Committee, the VA Organizational Assessment Subcommittee, and the VA Office of Labor and Management Relations (national union approval). The decision to publish was made by the study team.

Theoretical frameworks

We utilized the RE-AIM framework to develop VA-PALS Program Evaluation measures (16). This evaluation framework, which has been used in the cancer screening setting (17), provides a comprehensive structure to assess real-world clinical programs. The current study provides important measures within the “Implementation” domain of RE-AIM. This domain refers to whether an intervention or evidence-based practice was delivered with fidelity, or as originally intended (16). We also used the Consolidated Framework for Implementation Research (CFIR) in planning the overall program evaluation to understand contextual factors (e.g., team members, inner settings, processes at each VAMC) of lung cancer screening program implementation and the FRAME framework to study adaptations in lung cancer screening delivery (18, 19).

Recruitment and study population

Study inclusion criteria included healthcare team members [clinicians and staff (nurses, technologists, schedulers, administrative leaders)] and program directors employed at VAMCs participating in VA-PALS (Atlanta, Chicago-Hines, Cleveland, Denver, Indianapolis, Milwaukee, Nashville, Philadelphia, Phoenix, St. Louis). In this convenience sample, we recruited participants via email who expressed interest in continued research participation during a previous VA-PALS survey (20) and also recruited participants via champions who disseminated study information. Direct participant remuneration was not offered due to VHA policy. An initial recruitment goal of 30 participants was estimated. Study recruitment was stopped when thematic saturation was reached and no new emerging themes were identified.

Interviews

Semi-structured interview guides were tested, modified, and finalized by conducting pilot interviews with study team members. Participants were asked questions relating to: (1) employment history; (2) percentage of clinical practice residing in rural areas; (3) attitudes and beliefs about lung cancer screening; (4) lung cancer screening delivery processes; (5) roles and responsibilities; (6) teamwork and interprofessional communication; and (7) barriers and facilitators to implementation and screening. For staff and administrative professionals, questions pertaining to clinical decision-making were not asked. For participants whose facility had not yet implemented a lung cancer screening program, the questions were presented in a hypothetical frame. The interview guide consisted of additional questions for program directors relating to: (1) program team characteristics; (2) degree of leadership buy-in; (3) alignment with Veterans Integrated Service Network (VISN) priorities; (4) navigator retention; (5) navigator work length in days; and 6) establishment of navigators in permanent position (Supplementary Appendix S1).

Data collection

Study personnel contacted potential participants to schedule an interview date via email. Prior to the interview, participant agreement was obtained by telephone. Interviews were conducted via telephone in a secured office at the Nashville VAMC. Only the interviewer and interviewee were present. Each interview was conducted by a trained, female, MA psychologist (KB) using the appropriate interview guide for type of participant. Follow-up questions were asked to confirm understanding and facilitate more detailed discussion. Field notes were not made. The interviewer did not have a relationship with any of the participants prior to the interview. Participants were aware of the study's purpose to understand implementation of lung cancer screening in their VAMC and that the interviewer was a trained qualitative researcher without a clinical background in lung cancer screening. The audio-recorded interviews were transcribed and de-identified by a transcriptionist. Transcripts were not reviewed by participants and repeat interviews were not performed. Study personnel maintained recordings and study activity logs on a password-protected computer housed in a locked office at the Nashville VAMC. Each participant was assigned a unique participant identification number.

Qualitative data coding

Qualitative data coding and analysis was managed by the Vanderbilt University Qualitative Research Core, led by a MA psychologist (KB). A hierarchical coding system was derived inductively with preliminary review of the transcripts and deductively using the interview guides and CFIR (18). Major coding categories included (1) screening activity; (2) lung cancer screening program characteristics; (3) hospital organizational setting; (4) outer setting; (5) intervention characteristics; (6) patient factors; (7) communication; (8) barriers and facilitators; (9) specific examples; (10) process; (11) suggestions and needs; (12) provider/health team member; (13) practice/work experience; (14) world events; (15) change over time; and (16) notable quotes. Major coding categories were further divided from one to 13 subcategories, with some subcategories having additional levels of hierarchical division. Definitions and rules were established for the use of coding categories (Supplementary Appendix S2).

Three experienced qualitative coders independently coded two transcripts from each type of participant (provider, staff, program director). Coding was then compared, and any discrepancies resolved by reconciliation. Coders divided and independently coded the remaining transcripts. Each statement was treated as a separate quote and could be assigned up to 24 distinct codes (major code categories plus sub-categories). The coded transcripts were combined and sorted by code. Transcripts, quotations, and codes were managed using Microsoft Excel 2016 and SPSS version 28.0.

Conceptual model development

We used an iterative inductive deductive approach to the qualitative analysis, which resulted in development of a conceptual model (2123). Deductively, the model was guided by CFIR at the institution and systems level, and at the patient level by the theory of Self-Care Management for Vulnerable Populations, the Biopsychosocial Framework, and the Social Ecological Model (2426). Inductively, the details of the conceptual model were informed by the themes identified in the coded data.

Results

Study participants and demographics

Of 54 participants invited, five were not interested, in-eligible, or unable to participate, and 19 have unknown reasons for not participating. A total of 30 completed an interview between December 2020 and September 2021. Data from these 30 interviews comprised the final analytic sample. Table 1 demonstrates the characteristics of healthcare team members participating in an interview, including VA site, self-identified professional training, specialty, time in specialty, employment within the past 5 years, program director role, and perceptions of the proportion of rural patients served in clinical practice. Providers included oncology, primary care, pulmonology and radiology physicians, advanced practice providers, and staff.

Table 1.

Characteristics of interview participants.

Characteristic n (%), N = 30
VA Site
Atlanta 1 (3)
Chicago-Hines 2 (7)
Cleveland 3 (10)
Denver 3 (10)
Indianapolis 3 (10)
Milwaukee 3 (10)
Nashville 3 (10)
Philadelphia 5 (17)
Phoenix 3 (10)
St. Louis 4 (13)
Specialty
Oncology 2 (7)
Primary Care 10 (33)
Pulmonology 7 (23)
Radiology 7 (23)
Other or Not applicablea 4 (13)
Professional Training
Physician 14 (47)
Advanced Practice Provider 3 (10)
Nurse 6 (20)
Technician/Technologist 4 (13)
Administrative Support Assistant 2 (7)
Otherb 1 (3)
Time in Role
1–10 years 11 (37)
11–20 years 10 (33)
>20 years 9 (30)
Employment in past 5 years
Practiced within VA 20 (67)
Practice within and outside VA 10 (33)
Leadership
Lung Cancer Screening Program Director 10 (33)
Perception of clinical practice that is rural
≤10% 2 (7)
11%–25% 7 (23)
26%–50% 9 (30)
51%–75% 2 (7)
>76% 1 (3)
Missingc 9 (30)
a

Some participants were in Tobacco Cessation outside of Primary Care, Radiology, Oncology or Pulmonology or in a Medical support Assistant role that did not align with a particular specialty.

b

One participant was in a program analyst role.

c

Some participants were unsure of percentage of rural Veterans in their practice or this was not a part of their healthcare role.

The duration of interviews ranged from 18.23 to 66.29 min (median 41.39 min; IQR:32.08–51.11 min).

Conceptual model for rural barriers and facilitators of lung cancer screening

Figure 1 presents a conceptual model that organizes the qualitative results. The model has three main elements: (1) the institutional environment, (2) screening activities, and (3) the patient environment. There is bi-directional influence of both the institutional and patient environments that influences the planning and implementation of the screening elements. Healthcare professionals within local and the larger healthcare system develop linking relationships that can either facilitate or hinder the implementation of screening programs. These linking relationships, at the local systems and provider level, lead to collaborative engagement that can facilitate implementation of the screening programs. Within the patient environment, the full range of biological, psychological, social, and cultural influences interact to influence a patient's willingness to engage in screening. Within this model, there are numerous opportunities for interruption of the screening process. Adjustments to the process through adaptation and quality improvement can enhance the screening workflow processes.

Figure 1.

Figure 1

Conceptual model of rural barriers and facilitators of lung cancer screening implementation. This model was guided deductively by the Consolidated Framework for Implementation Research at the institution and systems level, and at the patient level by the theory of Self-Care Management for Vulnerable Populations, the Biopsychosocial Framework, and the Social Ecological Model (2426). This model was guided inductively by the themes identified in the coded data.

We use this overall model to discuss major and subthemes of rural barriers to and facilitators of lung cancer screening program implementation, which is summarized in Table 2. We use supporting quotes from participants. Each quote identifies the participant study identification number and healthcare team role.

Table 2.

Summary of rural barriers and facilitators of lung cancer screening Implementation.

Environmental context Level of influence Type of influence Barrier or facilitator Example from qualitative data
Institutional environment Systems Patient communication Facilitator Use of language common to rural communities during lung cancer screening shared-decision making conversations
Shared decision-making training tailored to rural Veterans who currently smoke and may fear screening results
Resource availability Facilitator Use of tool to manage patients being screening to ensure future care is coordinated
Mobile CT screening or screening done at community clinics (CBOCs)
Barrier Lack of access to rural clinics
Workload Barrier High personnel turnover
Lower priority among healthcare services
Provider Attitudes and beliefs Barrier Lack of centralized and specialized care for cancer screening and treatment
Knowledge Barrier Lack of knowledge of screening program activities and/or importance
Skills and capabilities Barrier Time delays in screening and coordination of care in rural settings
Lack of centralized screening program that manages and coordinates care
Lack of radiologist use of standardized reporting system for lung cancer screening results
External Institutional networks Facilitator Regional educational programs by specialists
Incentives Facilitator Offering monetary incentives for referring for screening
Patient environment Patient Modifiable vulnerabilities Barrier Patient need for transportation
Poor living conditions
Lack of education
Facilitator Development of telephone or video clinic
Scheduling screening on day when patient is already coming to the medical center or area
Lung cancer screening education specific for rural patients
Mailings to increase awareness of lung cancer screening among rural patients
Ecological modifiers Community Barrier Lack of discussions on health behaviors in rural communities
Misinformation
Rural norms and culture may not focus on some healthcare practices

Data obtained in 2020 to 2021 from interviews with radiology and primary care staff and providers and lung cancer screening program directors at 10 VAs participating in an enterprise-wide initiative, VA partnership to increase access to lung screening (VA-PALS); CBOC stands for community based outpatient clinic.

Institutional environment

Systems

Patient communication

Communities often have shared language and expressions. This participant describes using language common among rural Veterans during lung cancer screening shared decision-making to ensure comprehension:

“So when you communicate with shared decision making, you’re making sure that you are speaking to them in terms that they understand and can relate to and can appreciate and that you’re not really speaking over them or giving complex concepts or thoughts that they may not really understand.” (Participant 16, Program Director)

Some patients who are eligible for lung cancer screening currently smoke cigarettes and may or may not want to quit smoking. This participant describes needing assistance to communicate with rural patients who currently smoke with no plans to quit smoking and may have a fear of knowing whether they have lung cancer:

“I think some of them just feel like if they’re not going to quit, I mean so many people are just like I’m going to smoke. So, I don’t think they care about knowing but I’ve never had conversations like are you afraid to know. Yeah maybe some guidance on what those conversations on what those conversations should look like. You know they kind of are judgmental, leaning to some judgment …”. (Participant 8, Nurse Practitioner)

Resource availability

Lung cancer screening programs increase screening reach and sustainability with resources such as personnel (patient navigators) and access to CT scanners, tobacco cessation resources, and specialists in cancer care (27). One participant explained that rural access to care is a barrier:

“The VA doesn’t have a lot of contracts with really rural areas. So, if they’re going to go see mental health, to deal with their depression, anxiety, weight, smoking or whatever, it's still access. Finding somebody close to you who's taking VA payments and honestly a lot of our patients just kind of give up. Because it's easier to give up and keep smoking than it is to address it.” (Participant 7, Nurse Practitioner)

Participants highlighted the possibility of mobile CT screening, the need for a tool to help manage screening done in rural settings, and access to radiologists who have expertise in interpreting lung cancer screening imaging:

“We have one satellite that does it but it's also within 15 miles of the main medical center so the people that have declined being a part of the program almost always its because they don't want to get their scans done here. So, one of the things that I think will be a great idea moving forward is going to be some sort of mobile scanner. If you have a CAT scan on a truck and you can move it to the different areas, you're going to have a much more successful program.” (Participant 20, Program Director)

“I would love it if we had some way to have the screens done the right way either a mobile or local CBOC being able to take the CT the right way with low dose and get it sent to our radiologists that actually have experience reading it and then we can follow it up. The problem is we have no way to track those. We have no way to get the images.” (Participant 19, Program Director)

Workload

Participants discussed challenges related to rural provider workload. Rural facilities disproportionatly experience high provider turnover, due to limited resources and high workloads. This participant describes rural provider turnover and burnout as a challenge to maintaining a consistent screening program:

“… our rural clinics and our rural CBOCs tend to have a fairly large turnover in providers. So, I think that's a challenge, right? You know there's kind of a churn and burn and so I think some rural providers this may be lower on their list in the sense of what it requires.” (Participant 17, Program Director)

Providers manage multiple health care needs and problems for patients. Lung cancer screening may be less of a priority in the rural setting due to high workload:

“Rural meaning you’re spread out and they’re fewer of you and therefore it's more difficult to get consistency and to get buy in. It's hard to remember that the objective is to drain the swamp when you’re up to your [a**] in alligators. You take care of all sorts of stuff and wait a minute, ‘I don’t want to make more work for myself. I’ve got enough to do.’ So, I understand the problems involved …” (Participant 5, Physician)

Provider

Attitudes and beliefs

Several participants discussed their perceptions of healthcare in rural areas. These participants pointed out that surgery for cancer at academic medical centers is highly specialized and may not be available in rural communities:

“Some of the patients don’t understand that having cancer care or having surgery for stage 1 lung cancer being done by board certified thoracic surgeon is better than having surgery done by a general surgeon. So, having cancer care provided in an academic affiliated facility, and I’m biased in my statement, is probably better than some of the care than this patient would receive in their rural area.” (Participant 15, Program Director)

“Our belief here is that you know when you refer someone out for lung cancer screening with the mission act, its complicated and it's scattered care. I usually tell the patients you’re better off coming here. If we really have to do something where you live we’ll do it but we also want to have you within the healthcare system where we’re familiar with you and we can access your medical record, those kind of things.” (Participant 17, Program Director)

Knowledge

Lung cancer screening is a complex process that involves shared decision-making, tobacco cessation, yearly follow-up screenings, and coordination of care to evaluate and treat cancer (e.g., pulmonology, oncology, thoracic surgery, radiation oncology). Programs dedicated to lung cancer screening help track when Veterans are due for their next screening or need evaluation for possible cancer. This participant describes lack of provider knowledge of screening programs in rural areas:

“… If my Veteran has to drive down to our VA which takes an hour vs. an hour or two hours away to somewhere else, we usually just counsel them that hey you can’t just get it at your local place. Just come down here and get the scan and we’ll take care of it. So that's one thing and its hard to because I don’t think all primary care physicians particularly those in CBOCs who are seeing most of these rural Veterans completely get that either. So, we have tried to do outreach and education, but it is hard because its kind of a different way of looking at it.” (Participant 19, Program Director)

Skills and capabilities

This participant discussed delays associated with getting imaging done in rural communities and that imaging results do not use a standardized reporting system that informs healthcare providers of the next step in lung cancer screening care (i.e., results needing immediate work up, repeat early screening or repeat screening in 12 months).

“… Some of them don’t want to come to the VA to have the CT scan done so they get their LDCT done in a community imaging center and we can coordinate for that but it is sometimes a little bit tricky and more difficult to get those reports back into the VA. So there maybe a little bit of delay there. And associated with getting that report from a community imaging center sometimes the challenges that the report is not in the format that we want the data reported … that is what we call structure report …” (Participant 24, Program Director)

Participant expressed that rural hospitals lack lung cancer screening programs:

“… I’m a big firm believer that lung cancer screening is more than a CT scan. You cannot do lung cancer screening by just sending a Veteran to their local VA or their local hospital through the Mission Act and just getting a CT. It just doesn’t work …So its not helping our rural Veterans that much to have something like the Mission Act because they can go somewhere else but if they’re actually going to get the advantage of lung cancer screening and go to a screening program most of those are in urban areas.” (Participant 19, Program Director)

External

Institutional networks

VAs are organized into regional networks called Veterans Integrated Service Networks, or VISNs. This participant emphasizes the opportunity for on-site presentations to rural providers within their VISN:

“_____ is a specialty care access network, so it is a way for people in pulmonary and other specialties to give talks to providers that are located in CBOCs and smaller hospitals across our whole VISN, across the nation really. So, I think some of those providers out there love it because they don’t, you know …. there's talks all day for me around here but there's much fewer opportunities at the more rural settings. So, I think being able to put a name with a face and present cases or present guidelines or present plans is super helpful …” (Participant 17, Program Director)

Incentives

Reinforcement and incentives can be used to encourage provider behavior. This participant suggested that a nominal monetary incentive could help create rural provider buy-in:

“I think what you’re trying to do is taking a burden off the local practitioner and say all you have to do is send them into this study …That's going to get you some buy in. Particularly if they get a set amount of money to screen. Not to get people in because then you’ll have a bias of them just throwing it to people because they get money out of it. But if they get money for doing so many screenings screening that gets into the program and you get the money for doing that as part of your screening. You get five extra dollars for every time you do a H&P …” (Participant 5, Physician)

Patient environment

Patient

Modifiable vulnerabilities

One participant describes their program's approach to rural patient transportation challenges by developing a telephone clinic, as the Veteran can engage in elements of the lung cancer screening program remotely:

“So, the biggest challenge with the rural Veterans was transportation. We took care of that with our telephone clinic. So, the only time that we ask them to come to the VA is to get the CT scanning done.” (Participant 24, Program Director)

This participant suggested that another strategy to overcoming transportation challenges is to schedule screening appointments in conjunction with other medical care:

“Like when they come in for podiatry okay let's see if we can get it scheduled that day you know. Or like schedule your scan for this day and then we’ll let the clinic know and can they get you in that day too …So that helps some of the Veterans know like okay they can come in and get something else …That two-hour drive was worthwhile to come into town and do other errands while you’re here.” (Participant 13, Registered Nurse)

Participants noticed that some rural Veterans live in poor housing conditions:

“You know a lot a patients live in houses we would never dream of living in. Like our patients live in burned out mobile homes or other things where they’d be bad places. Home health can’t go out to him until he gets his house cleaned ….Right now, the main thing is the mouse infestation for him. But again, he continues smoking. Even if I do a CT of his chest and find something there, I seriously doubt if he's going to do anything about it.” (Participant 7, Nurse Practitioner)

This participant suggested the need for specific education for rural Veterans.

“I wonder if there's maybe sometimes a little more education that needs to be involved with the rural patients … most of them are like farmers or they don’t have jobs that they needed to go to college for. So maybe a lack of education with the rural Veterans maybe there.” (Participant 1, Registered Nurse)

When asked about the best way to inform rural Veterans about the screening program, this participant suggested mailings:

 “I think probably a mailing. I’ve been thinking about like my 80-year-old patient that I talked to the other day, he was saying he doesn’t have a computer or an iPad or anything, so I think rural patients are a lot like that too. They don’t always have technology but yeah, maybe sending a letter.”(Participant 8, Nurse Practitioner)

Ecological modifiers

Community

Community can influence health behaviors. This participant suggests that health behaviors may not be a topic of discussion in rural communities:

“I mean just sometimes they are being out in the country without a lot of neighbors and you know, being part of a small community where you know, health care may not be what people talk about in a rural setting. The awareness factor would just be a barrier.” (Participant 1, Registered Nurse)

This participant perceives that rural Veterans may obtain information from their community. This information could be inaccurate and deter them from participating in programs:

“… Cause you know the lady down the road didn’t have a lot of interaction and everybody knows everybody in some respect and in some areas just aren’t getting the right information. They’re getting it from their neighbor you know or from the guy at the store that they go to or a relative.” (Participant 13, Registered Nurse)

Community norms and culture are important contextual factors to consider in implementation of evidence-based practices. This was highlighted when one participant brought up cultural factors related to tobacco use and lung cancer screening among rural Veterans:

“Almost every one of them either smoke or dip and have their whole lives because they live on farms. I mean that's what they do. They’re country people and if they didn’t do it, their grandparents did it, so they do it. It's part of them.” (Participant 6, Licensed Practical Nurse)

Another participant perceived that rural communities may have their own healthcare practices or norms:

Well you know they have their own way of life. Things are quiet and don’t run the flow. You know they’re just kind of simple or you know have different ways of life or styles of what or how you take care of this and you know just going to the ….Oh back in my day in home care like they have their own family way of taking care of this problem or the things they would take or apply to themselves was very interesting.” (Participant 13, Registered Nurse)

Discussion

This study is among the first to describe VHA healthcare team members’ perceptions of barriers and facilitators of lung cancer screening program implementation in the rural setting. Systems-level barriers and facilitators included patient communication, resource availability, and workload. Provider-level barriers and facilitators included provider attitudes and beliefs, knowledge, and skills and capabilities. External to systems, institutional networks and incentives were discussed as facilitators. Perceived barriers and facilitators at the patient-level included modifiable vulnerabilities and the rural community was found to be an ecological modifier.

Commonly perceived barriers to implementation of new practices include lack of resources, staff shortage and turnover, lack of leadership buy-in, organizational culture, lack of expertise, and challenges with adapting the implementation of evidence-based practices (28, 29). A study by Gesthalter et al. compared lung cancer screening program implementation among three VAMCs that were early to adopt lung cancer screening. The study team conducted in-depth interviews with programmatic staff from 2013 to 2014 and found that managing workloads and obtaining primary care buy-in were major barriers (30). We found similar barriers in the need to manage workloads. For example, one participant described the need for a tracking system to help manage patients screened in rural communities and the need for specialized cancer screening and treatment care. However, the present study uniquely highlights perceived barriers at the patient-level. We discovered themes related to the need to tailor communication to rural Veterans, difficulty with transportation, and the potential influence rural communities may have on Veteran screening behavior. These findings add to the existing literature by highlighting areas for future lung cancer screening program growth and intervention development to increase rural screening reach and sustainability.

Improving the implementation of lung cancer screening in clinical practice offers an opportunity to not only improve overall lung cancer morbidity and mortality outcomes, but also to address existing disparities, such as improving lung cancer outcomes for Veterans living in rural areas. We found perceived barriers particular to rural Veterans included lack of resources, communication differences, transportation challenges, lack of clinics in rural communities, lack of lung cancer screening programs, provider knowledge gaps, and time delays in coordination of screening-related care. Several barriers found in our study, including provider lack of knowledge, geographic distance and transportation, and a lack of screening programs, are similar to those found in rural Colorado. In this study, researchers determined that a lack of a team-based and systematic and/or automated approach to conducting lung cancer screening resulted in few offers of lung cancer screening (31). Rural barriers found in the current study are similar to those of breast, cervical and colorectal cancer screenings and among rural populations (3236). These include difficulty accessing care due to structural barriers such as travel distance and transportation challenges as well as shortages of healthcare providers (34). The implementation of lung cancer screening programs with virtual clinic options in combination with mobile CT units that travel to rural areas may help to offset some of these challenges.

Potential strategies found in the present study to address rural disparities included education specific to rural Veterans, training in how to tailor communication to rural Veterans during shared decision-making, mobile lung cancer screening, and bundling screening with other appointments or activities closer to screening centers. The Community Services Preventive Task Force provides recommendations to increase breast, cervical and colorectal cancer screenings: provider audit and feedback (breast, cervical and colorectal), one-on-one education and patient reminders (breast and cervical), one-on-one education (colorectal) and group education (breast) (32). A recent review of the literature on rural communities found that individual and group education successfully increased breast and cervical cancer screening but that testing of strategies to increase patient adherence to yearly breast and cervical cancer screening were lacking (36). The use of a patient navigator may be a strategy to increase lung cancer screening adherence as well as breast, cervical and colorectal cancer screening (37). Further work is needed in this area.

VHA is dedicated to lung cancer screening, diagnosis, and treatment and has supported multiple initiatives over the last decade (14, 38, 39). With the goal of reaching rural Veterans, VHA uses virtual clinics (telephone and video) to screen Veterans, and we expect these services to remain in place to increase and sustain rural screening reach (19). VHA will be starting mobile lung cancer screening as part of the Lung Precision Oncology Program. This program started in 2021 with the following goals: (1) prioritizing screening to identify early-stage lung cancer; (2) offering genetic testing for treatment of advanced stage lung cancer; (3) improving access to precision-oncology clinical trials for treatment of advanced stage lung cancer; (4) increasing availability of clinical trials to provide new treatment options for lung cancer and (5) enabling rapid translation of discoveries into clinical care (39).

The use of established implementation science frameworks greatly strengthened this qualitative research study. Our study team leveraged the RE-AIM framework to develop the overall program evaluation for the VA-PALS parent study (14). Guided by “Implementation” domain in the RE-AIM framework, we designed this qualitative study of in-depth interviews with healthcare team members on the frontlines and in leadership positions to assess barriers and facilitators of lung cancer screening program implementation. Complementary research has demonstrated the use of RE-AIM to evaluate rural implementation barriers and facilitators of lung cancer screening in Colorado. In this qualitative study among rural primary care team members (clinicians, staff, patients) in multiple clinical settings (federally qualified health centers, private practices, and health system owned clinics), investigators used RE-AIM for data analysis and to process diagram how decisions impacted the different RE-AIM domains (i.e., Reach, Effectiveness, Adoption, Implementation, Maintenance) (31). In another study, a VA team has used RE-AIM to guide its implementation outcomes in a hybrid-effectiveness study that will test a lung cancer screening shared decision-making tool in New England VAs (40). Our study is unique in its application of RE-AIM to VHA program evaluation of lung cancer screening. Differing from the prior study by Gomes et al., we included radiology as well as primary care team members as well as program directors but did not include patients. This study also leveraged the expertise of an established qualitative research team, and qualitative study design that increases understanding of individual perspectives of rural barriers and facilitators to implementation of lung cancer screening and strategies to overcome these barriers.

Study limitations include our convenience sample of recruited participants via survey and champions rather than random selection, which may have introduced selection bias. Further, we do not have full demographic data (age, gender, race, ethnicity) on the overall characteristics of the healthcare providers nor those who declined an interview to allow for demographic characterization of responders and non-responders, which may introduce non-responder bias.

Understanding the barriers and facilitators of lung cancer screening program implementation in the rural setting as perceived by healthcare team members offers an opportunity to improve lung cancer outcomes while reducing disparities among the Veteran population. Our results may inform development and testing of strategies to improve lung cancer screening program reach, effectiveness and adoption.

Article Summary

Identifying rural barriers and facilitators of lung cancer screening program implementation in the Veterans Health Administration offers an opportunity to understand and improve rural-urban disparities and delivery of care for Veterans at high-risk for lung cancer.

Acknowledgments

The study team would like to thank the participants and VA-PALS champions for disseminating study information.

Funding Statement

This study was supported by the VA Office of Rural Health (LBS, JAL, CLR) with resources and use of facilities at VA Tennessee Valley Healthcare System, Nashville TN (LBS, KB, SB, JAL, RSD, CLR). Visit www.ruralhealth.va.gov to learn more. This study was also supported in part by the VA Lung Precision Oncology Program, VISN 9 Network, Vanderbilt-Ingram Cancer Center Support Grant CA68485 (LBS, JAL), Vanderbilt Scholars in T4 Translational Research (VSTTaR) K12 Program funded by the National Heart, Lung, and Blood Institute K12HL137943 (JAL, SK, CLR), a LUNGevity VA Research Scholars Award 2021-08 (JAL), an ASCO Conquer Cancer Young Investigator Award 2021YIA-9865677411 (JAL), and the Bristol Myers Squibb Foundation (DM).

Data availability statement

The dataset used in the present study is available from the corresponding author upon reasonable request.

Ethics statement

The studies involving humans were approved by Veterans Affairs (VA) Central Institutional Review Board (C-IRB E19-05), VA Tennessee Valley Healthcare System Research & Development Committee, the VA Organizational Assessment Subcomimittee, and the VA Office of Labor and Management Relations (national union approval). The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required from participants; agreement was obtained verbally and documented by the study team in agreement forms via telephone.

Author contributions

JL: conceptualization, funding acquisition, investigation, methodology, project administration, resources, validation, visualization, writing—original draft, writing—review and editing; KB: investigation, methodology, project administration, visualization, writing-original draft, writing—review and editing; DS: methodology, project administration, visualization, writing—review and editing; SB: project administration, writing—review and editing; CL: conceptualization, methodology, supervision, writing—review and editing; CH: funding acquisition, resources, supervision, writing—review and editing; DY: funding acquisition, resources, supervision, writing—review and editing; SY: funding acquisition, writing-review and editing; FH: funding acquisition, writing review and editing; RD: conceptualization, resources, supervision, writing—review and editing; TV: conceptualization, supervision, writing—review and editing; SK: funding acquisition, resources, supervision, writing—review and editing; DM: funding acquisition, resources, supervision, writing—review and editing; CA: conceptualization, methodology, supervision, writing—review and editing; CR: conceptualization, methodology, project administration, resources, supervision, validation, visualization, writing—review and editing; LS: conceptualization, funding acquisition, investigation, methodology, project administration, validation, visualization, writing—original draft, writing—review and editing. All authors contributed to the article and approved the submitted version.

Conflict of interest

JAL and LBS serve on the Steering Committee for the VA Tennessee Valley Healthcare System; JAL is a co-director of her VA's lung cancer screening program. None of the authors receive financial compensation for these roles. JAL is a board member of the Rescue Lung Rescue Life Society, a non-profit dedicated to the implementation of CT lung screening and does not receive financial compensation for this role. DFY is a named inventor on a number of patents and patent applications relating to the evaluation of diseases of the chest including measurement of nodules. Some of these, which are owned by Cornell Research Foundation (CRF), are non-exclusively licensed to General Electric. As an inventor of these patents, DFY is entitled to a share of any compensation which CRF may receive from its commercialization of these patents. He is also an equity owner in Accumetra, a privately held technology company committed to improving the science and practice of image-based decision making. DFY also serves on the advisory board of GRAIL. CIH is the President and serves on the board of the Early Diagnosis and Treatment Research Foundation. She receives no compensation from the Foundation. The Foundation is established to provide grants for projects, conferences, and public databases for research on early diagnosis and treatment of diseases. CIH is also a named inventor on a number of patents and patent applications relating to the evaluation of pulmonary nodules on CT scans of the chest which are owned by Cornell Research Foundation (CRF). Since 2009, CIH does not accept any financial benefit from these patents including royalties and any other proceeds related to the patents or patent applications owned by CRF.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/frhs.2023.1209720/full#supplementary-material

Datasheet1.docx (47KB, docx)

References

  • 1.National Lung Screening Trial Research T, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. (2011) 365(5):395–409. 10.1056/NEJMoa1102873 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. (2020) 382(6):503–13. 10.1056/NEJMoa1911793 [DOI] [PubMed] [Google Scholar]
  • 3.Force UPST. Screening for lung cancer: uS preventive services task force recommendation statement. JAMA. (2021) 325(10):962–70. 10.1001/jama.2021.1117 [DOI] [PubMed] [Google Scholar]
  • 4.Services CfMM. CAG-00439R Screening for Lung Cancer with Low Dose Computed Tomography (LDCT). (2022). Available at: https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=N&ncaid=304#:∼:text=In%202021%2C%20the%20most%20recent,within%20the%20past%2015%20years
  • 5.Fedewa SA, Kazerooni EA, Studts JL, Smith R, Bandi P, Sauer AG, et al. State variation in low-dose CT scanning for lung cancer screening in the United States. J Natl Cancer Inst. (2020) 113(8):1044–52. 10.1093/jnci/djaa170 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Liu B, Dharmarajan K, Henschke CI, Taioli E. State-level variations in the utilization of lung cancer screening among medicare fee-for-service beneficiaries: an analysis of the 2015 to 2017 physician and other supplier data. Chest. (2020) 157(4):1012–20. 10.1016/j.chest.2019.11.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Lewis JA, Samuels LR, Denton J, Edwards GC, Matheny ME, Maiga A, et al. National lung cancer screening utilization trends in the veterans health administration. JNCI Cancer Spectr. (2020) 4(5). 10.1093/jncics/pkaa053 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Health VAOoR. Rural Veterans (2022). Available at: https://www.ruralhealth.va.gov/aboutus/ruralvets.asp
  • 9.Spalluto LB, Lewis JA, Samuels LR, Callaway-Lane C, Matheny ME, Denton J, et al. Association of rurality with annual repeat lung cancer screening in the veterans health administration. J Am Coll Radiol. (2022) 19(1 Pt B):131–8. 10.1016/j.jacr.2021.08.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. (2011) 104(12):510–20. 10.1258/jrsm.2011.110180 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Westfall JM, Mold J, Fagnan L. Practice-based research–“blue highways” on the NIH roadmap. JAMA. (2007) 297(4):403–6. 10.1001/jama.297.4.403 [DOI] [PubMed] [Google Scholar]
  • 12.Brownson RC, Fielding JE, Green LW. Building capacity for evidence-based public health: reconciling the pulls of practice and the push of research. Annu Rev Public Health. (2018) 39:27–53. 10.1146/annurev-publhealth-040617-014746 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Highfield L, Bartholomew LK, Hartman MA, Ford MM, Balihe P. Grounding evidence-based approaches to cancer prevention in the community: a case study of mammography barriers in underserved African American women. Health Promot Pract. (2014) 15(6):904–14. 10.1177/1524839914534685 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lewis JA, Spalluto LB, Henschke CI, Yankelevitz DF, Aguayo SM, Morales P, et al. Protocol to evaluate an enterprise-wide initiative to increase access to lung cancer screening in the veterans health administration. Clin Imaging. (2020) 73:151–61. 10.1016/j.clinimag.2020.11.059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. (2007) 19(6):349–57. 10.1093/intqhc/mzm042 [DOI] [PubMed] [Google Scholar]
  • 16.Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. (1999) 89(9):1322–7. 10.2105/AJPH.89.9.1322 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Cragun D, DeBate RD, Vadaparampil ST, Baldwin J, Hampel H, Pal T. Comparing universal Lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through. Genet Med. (2014) 16(10):773–82. 10.1038/gim.2014.31 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. (2009) 4:50. 10.1186/1748-5908-4-50 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Strayer TE, Spalluto LB, Burns A, Lindsell CJ, Henschke CI, Yankelevitz DF, et al. Using the framework for reporting adaptations and modifications-expanded (FRAME) to study adaptations in lung cancer screening delivery in the veterans health administration: a cohort study. Implement Sci Commun. (2023) 4(1):5. 10.1186/s43058-022-00388-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Spalluto LB, Lewis JA, Stolldorf D, Yeh VM, Callaway-Lane C, Wiener RS, et al. Organizational readiness for lung cancer screening: a cross-sectional evaluation at a veterans affairs medical center. J Am Coll Radiol. (2021) 18(6):809–19. 10.1016/j.jacr.2020.12.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Fereday J, Muir-Cochrane E. Demonstrating rigor using thematic analysis: a hybrid approach of inductive and deductive coding and theme development. Int J Qual Methods. (2006) 5(1):80–92. 10.1177/160940690600500107 [DOI] [Google Scholar]
  • 22.Tjora A. Qualitative research as stepwise-deductive induction: A stepwise-deductive inductive approach: routledge. 1st ed. London: Routledge; (2018). [Google Scholar]
  • 23.Azungah T. Qualitative research: deductive and inductive approaches to data analysis. Qual Res J. (2018) 18(4):383–400. 10.1108/QRJ-D-18-00035 [DOI] [Google Scholar]
  • 24.Dorsey CJ, Murdaugh CL. The theory of self-care management for vulnerable populations. J Theory Constr Test. (2003) 7(2):43–9. [Google Scholar]
  • 25.McLeroy KR, Bibeau D, Steckler A, Glanz K. An ecological perspective on health promotion programs. Health Educ Q. (1988) 15(4):351–77. 10.1177/109019818801500401 [DOI] [PubMed] [Google Scholar]
  • 26.Borrell-Carrio F, Suchman AL, Epstein RM. The biopsychosocial model 25 years later: principles, practice, and scientific inquiry. Ann Fam Med. (2004) 2(6):576–82. 10.1370/afm.245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Lewis JA, Samuels LR, Denton J, Matheny ME, Maiga A, Slatore CG, et al. The association of health-care system resources with lung cancer screening implementation: a cohort study. Chest. (2022) 162(3):701–11. 10.1016/j.chest.2022.03.050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bach-Mortensen AM, Lange BCL, Montgomery P. Barriers and facilitators to implementing evidence-based interventions among third sector organisations: a systematic review. Implement Sci. (2018) 13(1):103. 10.1186/s13012-018-0789-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kegeles SM, Rebchook G, Tebbetts S, Arnold E, Team T. Facilitators and barriers to effective scale-up of an evidence-based multilevel HIV prevention intervention. Implement Sci. (2015) 10:50. 10.1186/s13012-015-0216-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Gesthalter YB, Koppelman E, Bolton R, Slatore CG, Yoon SH, Cain HC, et al. Evaluations of implementation at early-adopting lung cancer screening programs: lessons learned. Chest. (2017) 152(1):70–80. 10.1016/j.chest.2017.02.012 [DOI] [PubMed] [Google Scholar]
  • 31.Gomes R, Nederveld A, Glasgow RE, Studts JL, Holtrop JS. Lung cancer screening in rural primary care practices in Colorado: time for a more team-based approach? BMC Prim Care. (2023) 24(1):62. 10.1186/s12875-023-02003-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sabatino SA, Lawrence B, Elder R, Mercer SL, Wilson KM, DeVinney B, et al. Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. Am J Prev Med. (2012) 43(1):97–118. 10.1016/j.amepre.2012.04.009 [DOI] [PubMed] [Google Scholar]
  • 33.Charlton M, Schlichting J, Chioreso C, Ward M, Vikas P. Challenges of rural cancer care in the United States. Oncology (Williston Park). (2015) 29(9):633–40. . [PubMed] [Google Scholar]
  • 34.Schoenberg NE, Studts CR, Hatcher-Keller J, Buelt E, Adams E. Patterns and determinants of breast and cervical cancer non-screening among Appalachian women. Women Health. (2013) 53(6):552–71. 10.1080/03630242.2013.809400 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Goins RT, Williams KA, Carter MW, Spencer M, Solovieva T. Perceived barriers to health care access among rural older adults: a qualitative study. J Rural Health. (2005) 21(3):206–13. 10.1111/j.1748-0361.2005.tb00084.x [DOI] [PubMed] [Google Scholar]
  • 36.Atere-Roberts J, Smith JL, Hall IJ. Interventions to increase breast and cervical cancer screening uptake among rural women: a scoping review. Cancer Causes Control. (2020) 31(11):965–77. 10.1007/s10552-020-01340-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Spalluto LB, Lewis JA, LaBaze S, Sandler KL, Paulson AB, Callaway-Lane C, et al. Association of a lung screening program coordinator with adherence to annual CT lung screening at a large academic institution. J Am Coll Radiol. (2020) 17(2):208–15. 10.1016/j.jacr.2019.08.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Kinsinger LS, Anderson C, Kim J, Larson M, Chan SH, King HA, et al. Implementation of lung cancer screening in the veterans health administration. JAMA Intern Med. (2017) 177(3):399–406. 10.1001/jamainternmed.2016.9022 [DOI] [PubMed] [Google Scholar]
  • 39.Affairs V. VA Lung Precision Oncology Program. (2021). Available at: https://www.research.va.gov/programs/lpop/default.cfm
  • 40.Khanna A, Fix GM, McCullough MB, Herbst AN, Li M, Miano D, et al. Implementing shared decision-making for lung cancer screening across a veterans health administration hospital network: a hybrid effectiveness-implementation study protocol. Ann Am Thorac Soc. (2022) 19(3):476–83. 10.1513/AnnalsATS.202105-620SD [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Datasheet1.docx (47KB, docx)

Data Availability Statement

The dataset used in the present study is available from the corresponding author upon reasonable request.


Articles from Frontiers in Health Services are provided here courtesy of Frontiers Media SA

RESOURCES